Avid Bioservices Announces Proposed Public Offering of Common Stock

Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors

Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2021 and Recent Developments

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2021 After Market Close on December 2, 2020

Avid Bioservices Announces Move to Virtual-Only Annual Meeting of Stockholders on October 20, 2020

Avid Bioservices to Participate in 18th Annual Morgan Stanley Global Healthcare Conference

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2020 and Recent Developments

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

Avid Bioservices Selected by Mapp Biopharmaceutical, Inc. for Clinical Development of Novel Human Monoclonal Antiviral Antibody